XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.15

-0.7%

Jan 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (9183)	3/14/1999 1:31:00 AM
From: aknahow	Read Replies (1) of 17367

No, not at all. Just acting like most other people. Believe what you want to believe and ignore anything that contradicts it. <g> Actually it has taken months to get a fix on u.k. mortality. The reference may not be correct but it makes waiting for the end of the trial easier. Anyone in the u.k. that has access to accurate 1998 data on meningococcal sepsis stratified by severity is in a great position to bet on an almost sure thing or walk away unharmed. BTW I thought it was clear. If the mortality rate in 97 for 8 or higher on the Glasgow scale was 30% it is doubtful it is suddenly below 20%. The target should be around 35 and the failure to reach the target should be due to Neuprex rather than an improvement in the level of care. But this is in theory only. I have no idea if it is true.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next